Study ID: FSS-AS-201

Study Title

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Teva Identifier

FSS-AS-201

ClinicalTrials.gov Identifier

NCT01772368

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Fp MDPI | Drug: FS MDPI | Drug: Advair Diskus | Drug: Albuterol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

01/01/2013 - 06/01/2013

Phase

Phase 2

Study Type

Interventional